This metabolite includes a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 about fifty% in the guardian drug. Plasma concentrations of this metabolite are approximately 40% of Those people witnessed for sildenafil, so which the metabolite accounts for approximately twenty% of sildenafil’s pharmacologic results.Corre